🇺🇸 FDA
Patent

US 9587232

Mutated organophosphorus acid anhydrolases and their uses thereof

granted A61KA61K38/465

Quick answer

US patent 9587232 (Mutated organophosphorus acid anhydrolases and their uses thereof) held by The United States of America as represented by the Secretary of the Army expires Mon Mar 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as represented by the Secretary of the Army
Grant date
Tue Mar 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K38/465